I.G. Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

I.G. Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-382,140	Closed	-$17.6M	–	701
2016 Q3	$17.6M	Sell	382,140 -2,535	-0.7%	-$132K	0.07%	177
2016 Q2	$19.3M	Buy	384,675 +24,146	+7%	+$1.29M	0.08%	158
2016 Q1	$19.3M	Sell	360,529 -49,106	-12%	-$2.88M	0.08%	151
2015 Q4	$26.9M	Buy	409,635 +44,600	+12%	+$2.76M	0.11%	115
2015 Q3	$20.6M	Buy	365,035 +10,832	+3%	+$702K	0.09%	134
2015 Q2	$20.9M	Buy	354,203 +48,838	+16%	+$3.01M	0.08%	144
2015 Q1	$19M	Buy	305,365 +166,897	+121%	+$9.7M	0.07%	157
2014 Q4	$7.96M	Buy	138,468 +2,535	+2%	+$141K	0.03%	273
2014 Q3	$7.31M	Buy	135,933 +14,838	+12%	+$786K	0.03%	281
2014 Q2	$6.35M	Buy	121,095 +13,727	+13%	+$702K	0.02%	310
2014 Q1	$5.67M	Sell	107,368 -799	-0.7%	-$36.9K	0.02%	320
2013 Q4	$4.33M	Sell	108,167 -3,397,441	-97%	-$134M	0.02%	352
2013 Q3	$132M	Sell	3,505,608 -14,646	-0.4%	-$571K	0.5%	40
2013 Q2	$138M	Buy	+3,520,254	New	+$137M	0.56%	40

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

I.G. Investment Management's TEVA Position: Q4 2016 in Review

I.G. Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 382,140 shares — an estimated $17.6M sold.

I.G. Investment Management first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $138M in Q2 2013. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

I.G. Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
I.G. Investment Management sold 382,140 Teva Pharmaceuticals shares in Q4 2016, an estimated $17.6M.
I.G. Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
I.G. Investment Management's Teva Pharmaceuticals position peaked at $138M in Q2 2013.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.